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Summary 
Through analyses of publicly-available human serological data, we identify a previously-
unrecognised persistence of Toxoplasma gondii sporozoite-specific antibodies. We discuss 
how sporozoite-specific serology can elucidate the transmission dynamics of T. gondii and 
help quantify the importance of transmission routes to inform public health initiatives.   
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Background. Horizontal transmission of Toxoplasma gondii occurs primarily via ingestion of 
environmental oocysts or consumption of undercooked/raw meat containing cyst-stage 
bradyzoites. The relative importance of these two transmission routes remains unclear. 
Oocyst infection can be distinguished from bradyzoite infection by identification of IgG 
antibodies against T. gondii-embryogenesis-related protein (TgERP). These antibodies are, 
however, thought to persist for only 6-8 months in human sera, limiting the use of TgERP 
serology to only those patients recently exposed to T. gondii. Yet recent serological survey 
data indicate a more sustained persistence of anti-TgERP antibodies. Elucidating the 
duration of anti-TgERP IgG will help to determine whether TgERP serology has 
epidemiological utility for quantifying the relative importance of different routes of T. gondii 
transmission. 
Methods. We developed a sero-catalytic mathematical model to capture the change in 
seroprevalence of non-stage-specific IgG and anti-TgERP IgG antibodies with human age. 
The model was fitted to published datasets collected in an endemic region of Brazil to 
estimate the duration of anti-TgERP IgG antibodies, accounting for variable age-force of 
infection profiles and uncertainty in the diagnostic performance of TgERP serology. 
Results. We found that anti-TgERP IgG persists for substantially longer than previously 
recognised, with estimates ranging from 8.3 to 41.1 years. The Brazilian datasets were 
consistent with oocysts being the predominant transmission route in these settings.  
Conclusions. The longer than previously recognised duration of anti-TgERP antibodies 
indicates that anti-TgERP serology could be a useful tool for delineating T. gondii 
transmission routes in human populations. TgERP serology may therefore be an important 
epidemiological tool for informing the design of tailored, setting-specific public health 
information campaigns and interventions. 
Keywords. Toxoplasma gondii; oocysts; bradyzoites; TgERP; IgG; persistence; 
mathematical model.  
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Approximately one third of the world's human population are seropositive for the 
apicomplexan protozoan parasite Toxoplasma gondii. Members of the cat family (Felidae) 
are the only known definitive hosts of T. gondii, yet the parasite can infect all warm-blooded 
animals as secondary or intermediate hosts [1]. Toxoplasmosis can have a profound impact 
on human health, not only in terms of congenital disease in infants, severe pathologies in 
immunocompromised individuals (e.g. AIDs and organ transplant patients) [2] and acute, 
symptomatic infections in adults during outbreaks [3–5], but also through its association with 
a large burden of behavioural and neurological disorders, including schizophrenia, in 
immunocompetent individuals [6–9]. T. gondii is also of major economic importance for the 
livestock industry, being responsible for approximately 23% of ovine abortions in Europe and 
the USA [10]. 
There are three predominant routes of T. gondii transmission: vertical transmission 
from mother to offspring, and two forms of horizontal transmission. Horizontal transmission 
involves either consumption of bradyzoite tissue cysts from infected secondary/intermediate 
hosts, or ingestion of oocysts shed in the faeces of infected felids [11]. Understanding the 
relative significance of each route in different epidemiological settings has important 
implications. First, public health information campaigns and interventions aimed at limiting 
the risk of human infection will be most effective if they are closely aligned with local 
epidemiology. Second, whether an infection is of oocyst or bradyzoite origin may relate to 
disease severity and clinical outcome, and may therefore be important for prognosis and 
clinical management [3,12]. 
Currently, the relative epidemiological predominance of oocyst- versus bradyzoite-
transmission remains elusive. It has been proposed that due to a short duration of oocyst 
shedding and the time required for sporulation, this route is a minor contributor to human 
infection [13]. However, it is likely that the predominant horizontal infection route varies 
globally according to context-specific eating and hygiene practices [14]. For example, in 
Poland, where approximately 80% of livestock have been reported as T. gondii-seropositive, 
bradyzoites from meat have been suggested to comprise a significant source of infection 
[15]. By contrast, in parts of Brazil, where many people live in poor socioeconomic conditions 
(and in a warm, humid climate favourable to long-term oocyst survival [16]), T. gondii 
infection has been largely attributed to oocysts [17].  
The discovery that antibodies raised against an 11-kDa sporozoite-specific protein, T. 
gondii embryogenesis-related protein (TgERP), distinguish oocyst from bradyzoite infection 
has made investigations into the route of T. gondii transmission possible [18]. However, 
interpretation of results from this serological assay—and its potential use as an 
epidemiological tool to understand horizontal transmission—is hindered by the presumed 
short duration (6-8 months) of anti-TgERP IgG antibodies. However, recent serosurvey data 
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[19,20] showing a relatively high seroprevalence of anti-TgERP IgG, compared to non-stage-
specific IgG, casts doubt on the transience of anti-TgERP IgG [21–23]. Mathematical 
modelling, by capturing the processes driving infection dynamics in populations, can help 
resolve this paradox and hence, in this context, can be used as a tool to estimate the 
duration of anti-TgERP IgG antibodies from seroprevalence data. 
Here, we present a sero-catalytic mathematical model which we fit to seroprevalence 
data from an endemic region of Brazil. We estimate the duration of anti-TgERP IgG 
antibodies, age-force of infection profiles and provide comprehensive sensitivity analyses to 
confirm the robustness of our findings to key assumptions. We discuss how the expanded 
use of TgERP serology in epidemiological studies will improve our understanding of the 
transmission dynamics of T. gondii and we highlight its potential as an epidemiological tool to 
inform the design of tailored, setting-specific public health initiatives.  
 
METHODS 
Epidemiological setting and serological data 
Age-stratified data on serum anti-T. gondii non-stage-specific IgG and anti-TgERP IgG were 
identified by searching Google Scholar, Web of Science and PubMed using the terms 
“Toxoplasma gondii OR T. gondii OR toxoplasmosis” and “seroprev*”, along with either 
“oocyst*” or “sporozoite*”. Three studies were initially identified [19,20,24], one of which was 
excluded from the analysis due to a limited sample size (N=10 for anti-TgERP IgG) [24]). The 
remaining two datasets were both collected in Campos dos Goytacazes, a municipality in the 
north of Rio de Janeiro state, Brazil, where T. gondii infection is highly endemic and primarily 
associated with the oocyst route of infection [17]. One dataset was generated using a 
stratified sampling approach to collect blood samples from individuals (N=128) living in areas 
at different risk of groundwater contamination (hereafter referred to as the ‘population data’) 
[19]. The other dataset was generated using a geographically-representative sample of 
individuals associated with 10 regional public schools (N=380), including students, students’ 
parents and staff (hereafter referred to as the ‘schools data’) [20].  
Non-stage-specific serum IgG was measured using a standard enzyme-linked 
immunosorbent assay (ELISA) for the schools data and using a modified agglutination test 
(MAT) for the population data. For the population data [19], serum anti-TgERP IgG was 
measured using a standard deviation (SD) cut-off ELISA (where a sample is considered 
positive if its optical density is three SDs above the mean of seronegative controls) and, for 
the schools data [20], using both a SD cut-off ELISA and a receiver operating characteristic 
(ROC) curve cut-off ELISA (where known-positive and negative samples are analysed and a 
suitable cut-off chosen to optimise diagnostic performance). Seroprevalence estimates with 
95% confidence intervals (CIs) [25] are shown in Table 1. 
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Mathematical model 
A sero-catalytic model [26,27] was built in R [28] based on a system of ordinary differential 
equations (ODEs) to estimate the duration of anti-TgERP IgG and age-force of infection 
profiles by fitting to the age-stratified serosurvey data (Supplementary Methods). The model 
describes age-seroprevalence profiles of non-stage-specific IgG and anti-TgERP IgG based 
on rates of seroconversion following exposure (and continuous re-exposure) to T. gondii 
oocysts or bradyzoites and subsequent antibody-specific rates of seroreversion (Figure 1). 
We assumed that all individuals were born seronegative for both antibodies, and that the rate 
of seroconversion for each antibody was driven by an age-dependent force of infection (the 
per capita rate at which susceptible individuals acquire infection per unit time) and a 
parameter defining the proportion of oocyst-derived (as opposed to bradyzoite-derived) 
infections.  
The force of infection was assumed to take one of four competing functional forms. 
The most complex, an exponentially damped relationship [29], initially increases with age to 
a peak and subsequently declines. The simpler functions describe, respectively, a linear 
relationship with age (with and without a positive intercept at birth) and a constant (age-
independent) force of infection (Supplementary Methods and Supplementary Table S1). We 
varied the proportion of oocyst-derived infections between 0.50 and 1.0 in accordance with 
local epidemiological knowledge suggesting that oocysts account for the majority of 
infections in Campos dos Goytacazes [17]. The rate of seroreversion was assumed to be 
zero for non-stage-specific IgG, a common assumption indicative of a life-long antibody 
response [21–23] (but see [30,31] for alternative arguments). We estimated the rate of 
seroreversion (1/duration) of anti-TgERP IgG.  
 
Diagnostic performance characteristics 
The modelled seroprevalence of non-stage-specific IgG and anti-TgERP IgG was adjusted 
for the imperfect sensitivity and specificity of the respective diagnostics [32]. Sensitivity and 
specificity of the non-stage-specific IgG ELISA (schools data) was set at 94.5% and 98.7% 
respectively, in accordance with published estimates (Supplementary Table S2). We also 
used these values for the sensitivity and specificity of the MAT (population data) because the 
MAT diagnostic performance is very similar to that of the ELISA (Supplementary Table S3). 
 The sensitivity and specificity of the ROC curve cut-off TgERP ELISA was set to  
91.5% and 75.4% respectively in accordance with published estimates (Supplementary 
Table S2) [20]. Since no published estimates were available for the SD cut-off TgERP ELISA 
diagnostic values, a sensitivity analysis was performed, setting a range of values such that 
sensitivity for the SD cut-off ELISA was lower than the ROC curve cut-off ELISA and the 
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 7 
specificity higher (since there is a higher proportion of positive cases in the ROC versus SD 
data [20], Supplementary Table S4). For further details, see the Supplementary Methods.  
 
Maximum likelihood estimation of model parameters 
A maximum likelihood approach was used to estimate the rate of seroreversion of anti-
TgERP IgG and parameters defining the age-force of infection profile using a quasi-Newton 
procedure [33], assuming a binomial distribution for the data. For each dataset, the model 
was fitted simultaneously to the age-stratified seroprevalence of non-stage-specific IgG and 
anti-TgERP IgG (for the schools dataset, this meant simultaneously fitting to both types of 
anti-TgERP data and non-stage-specific IgG data). The model was fitted repeatedly to the 
data using different functional forms of the age-force of infection profile, different assumed 
values of the proportion of oocyst-derived infections, and different diagnostic performance 
characteristics of the SD cut-off anti-TgERP ELISA. The likelihood of each fitted model was 
recorded and compared (using likelihood ratio tests, LRTs, for models with different age-
force of infection functions) to determine the best-fitting yet most parsimonious model. 
 
RESULTS 
Age-force of infection profiles  
Across all combinations of the sensitivity and specificity of SD cut-off anti-TgERP ELISA, we 
found that the best-fitting age-force of infection profile (by LRT) for the population data was 
consistently a constant (age-independent) force of infection; whereas for the schools data, 
the best fitting model was a linearly increasing function of age (with and without a positive 
intercept, depending the assumed sensitivity and specificity) (Table 2). For details, see 
Supplementary Tables S5 and S6. 
 
Proportion of oocyst-derived infections 
For the population data [19], increasing the proportion of oocyst infections from 0.5 to 1 led to 
a consistent but small tendency for the log likelihood to increase across all age-force of 
infection profiles. For the schools data [20], there was no consistent trend in the log likelihood 
with an increasing proportion of oocyst infections. However, estimates of anti-TgERP IgG 
duration did not fall within a plausible range until approximately 80% of infections were 
assumed to be oocyst-derived (i.e. for lower than 80% oocyst infections, the duration of anti-
TgERP IgG was estimated as longer than an average human lifespan). We therefore 
considered that the proportion of oocyst infections was likely to be high (consistent with local 
epidemiological knowledge [17]) and fixed this parameter to 1 for final inference on the rate 
of seroreversion (duration) of anti-TgERP antibodies. For details, see Supplementary Tables 
S7 and S8. 
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Duration of anti-TgERP IgG antibodies 
Maximum likelihood estimates of the duration (1/rate of seroreversion) of anti-TgERP IgG 
antibodies ranged between 20.7 to 41.1 years for the population data and between 8.3 and 
18.9 years for the schools data, depending on the assumed sensitivity and specificity of the 
SD cut-off TgERP ELISA, and using the best-fit age-force of infection profile. We found little 
variation in the likelihood of the data of different sensitivity and specificity values when fitting 
to the population data (Figure 2a and Supplementary Table S5), while for the schools data 
the best-fitting model included a SD cut-off TgERP ELISA sensitivity and specificity of 80% 
and 95% respectively, yielding a best point estimate for the duration of anti-TgERP IgG 
antibodies of 18.9 years (Figure 2b and Supplementary Table S6). The fitted non-stage-
specific IgG and anti-TgERP IgG seroprevalence profiles compared to the observed schools 
and population data are shown in Figure 3 and Figure 4 respectively. 
 
 
 
 
 
DISCUSSION 
Using a sero-catalytic modelling approach incorporating the only substantial and publicly-
available TgERP serosurvey datasets [19,20], we estimate that the duration of anti-TgERP 
IgG antibodies following exposur  to T. gondii oocysts is between 8.3 and 41.1 years, 
substantially longer than the hitherto proposed 6-8 months [18]. If this finding can be 
confirmed in other epidemiological settings, the scope of TgERP serology may be greatly 
expanded from a predominantly clinical context, for patients with known recent exposure to 
T. gondii, to the epidemiological domain, to quantify the importance of the oocyst versus 
bradyzoite route of transmission in endemic communities. This could ultimately help to 
provide a stronger evidence-base to inform public health initiatives aiming to control 
toxoplasmosis. 
 Hill and colleagues [18]—who first demonstrated the use of TgERP serology to 
identify oocyst-derived infections—originally proposed the 6-8 month duration of the anti-
TgERP IgG response. They estimated this using IgG avidity tests and TgERP serology on a 
small cohort of experimentally infected pigs (i.e. with known time of exposure) in addition to 
historical human samples paired with information on probable timing of exposure.  
However, since the IgG avidity index classification of chronic infection excludes primary 
infection in the last three months but has no upper limit for infection date [18], this estimate 
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 9 
may have underestimated the duration of the anti-TgERP IgG response. Indeed, in line with 
a longer persistence of anti-TgERP IgG response, Vieira and colleagues [19] found that all 
anti-TgERP IgG positive individuals were negative for IgM, an observation strongly indicative 
of chronic infection. IgM titres usually persist for 6-9 months post infection and in a small 
minority of cases have been shown to be detectable for two or more years [23]. These 
observations accord with our main finding, suggesting a previously unrecognised persistence 
of anti-TgERP IgG in oocyst-infected individuals. 
 Our results also indicate two distinct age-force of infection profiles, a constant (age-
independent) [19] and linearly increasing [20] relationship with age, despite both analysed 
datasets being collected from the same endemic region in Brazil. These differences have a 
number of possible explanations. First, since the two studies sampled individuals of very 
different age ranges, 8-59 years [19] and 0-28 years [20], the force of infection profiles could 
be consistent with a rapid increase in early childhood which later plateaus or decreases by 
adolescence and adulthood [34]. Second, while the population data were generated by 
stratified sampling of individuals from residential areas according to groundwater 
contamination risk [19], the schools data were generated by sampling individuals associated 
with 10 regional public schools [20]. It is thus possible that these two study populations, 
despite coming from the same endemic setting, differ with respect to other unmeasured 
epidemiologically relevant variables. 
 Interestingly, for the model fitted to the schools data [20], the best-fitting model 
contained a term for a non-zero force of infection at birth, which could be indicative of 
congenital infection. Indeed, in Brazil there is a very high rate of T. gondii vertical 
transmission, with 5-23 neonates congenitally infected per 10,000 births [35]. Given the force 
of infection estimated here—0.015 per person per year in new-borns—this is equivalent to 
150 neonates (30 to 270) congenitally infected per 10,000 births. This estimate is likely 
higher than that of a previous study for the whole of Brazil [35] due to the local 
epidemiological characteristics of this high-transmission intensity setting, or because of 
systemic under-reporting of congenital infection. Alternatively, since our model does not 
account for passive transmission of maternal IgG to neonates, this estimate could, in part, 
indicate the prevalence of maternally-derived antibodies, rather than de novo antibody 
production following congenital infection [36]. Nonetheless, a non-zero force of infection at 
birth is unlikely due to setting-specific variation in diagnostic sensitivity or specificity, since 
the TgERP ROC curve cut-off diagnostic values were obtained directly from the schools 
study [20]. Thus, our adjustment for imperfect diagnostic performance should provide a 
reasonably accurate measure of the true underlying force of infection. While the model is 
consistent with some level of congenital infection, without data on the seroprevalence in 
neonates, it is difficult to establish this with certainty. 
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 We fully acknowledge the mathematical model proposed here relies on a number of 
assumptions that could bias our estimates of the age-force of infection relationship and the 
duration of the anti-TgERP IgG response. First, it is assumed that the force of infection 
remains constant over time (note that this is distinct from age-associated changes, which are 
modelled explicitly [37]). A previous study incorporated time-related changes in the force of 
infection of T. gondii in Sweden, yielding lower incidence estimates of maternal 
toxoplasmosis than would be expected if the force of infection was temporally stable [29]. If 
the force of infection had been recently increasing very rapidly in the study setting, it is 
possible that the duration of anti-TgERP IgG could have been overestimated. However, in 
the absence of dramatic secular changes in environmental, socioeconomic or cultural 
factors, there is little evidence to suggest this.  
Second, the estimates presented here use data collected from a known high-
transmission region of Brazil [17,35], which may limit the generalisability of our findings. For 
example, it is possible that the duration of anti-TgERP IgG antibodies may be related to the 
cumulative lifetime exposure to T. gondii (TgERP) antigens rather than their production being 
continually ‘boosted’ by repeated exposure, as is modelled here. This phenomenon is 
observed for the immune response to specific antigens of Plasmodium falciparum [38]. This 
hypothesis could be tested by adapting the current sero-catalytic model to link antibody 
duration to cumulative exposure to T. gondii and the model fitted to seroprevalence data 
collected from settings with markedly different intensities of transmission. To date there is 
only one study available in the literature conducted in a low transmission region, in Scotland. 
However the study identified only one anti-TgERP IgG positive case out of 10 individuals 
who had recently seroconverted [24] and hence had insufficient power for inclusion in our 
analyses. More abundant data on anti-TgERP seroprevalence from low endemicity settings 
would thus be highly valuable for further understanding T. gondii antibody dynamics.  
Third, South America has an unparalleled diversity of T. gondii genotypes, with an 
abundance of ‘atypical’ genotypes rarely found elsewhere (those not conforming to the 
traditional type I-III designation) [35,39,40]. Since TgERP plays a role in T. gondii 
embryogenesis, a key process in the sexual cycle, one may predict its expression to not 
differ significantly across parasite strains. In contrast, the duration of the antibody response 
may be expected to differ among strains and therefore show geographic heterogeneity. 
Hence, we reiterate, a key next step is testing our findings using data from other geographic 
and epidemiological settings. 
Sero-catalytic modelling is used to analyse epidemiological data from a diverse array 
of pathogens [26] and, notably, for planning interventions against human malaria [41,42], an 
apicomplexan cousin of T. gondii. Here we have applied this approach to estimate the 
duration of the anti-TgERP IgG response following exposure to T. gondii oocysts, finding it is 
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sustained for much longer than previously thought. If these findings can be validated in 
additional epidemiological settings, TgERP serology could potentially be used to quantify the 
relative importance of T. gondii transmission routes (oocyst versus bradyzoite) in endemic 
communities. Such setting-specific understanding would be valuable for informing public 
health information campaigns and designing tailored intervention strategies.  
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TABLES 
Table 1. Seroprevalence of Toxoplasma gondii measured by two serological 
diagnostics in Campos dos Goytacazes, Rio de Janeiro state, Brazil 
 
Age in years 
(n) 
Non-stage-specific IgG 
positive (%; 95% CI) 
Anti-TgERP IgG positive using 
ROC curve cut-off (%; 95% CI) 
Anti-TgERP IgG positive 
using SD cut-off (%; 95% CI) 
Reference 
8-19 (23) 47.8 (29.2, 67.0) - 39.1 (22.1, 59.3) [19] 
20-29 (27) 66.7 (47.7, 81.5) - 55.6 (37.3, 72.4)  
30-39 (21) 90.5 (69.9, 98.6) - 52.4 (32.4, 71.7)  
40-49 (15) 73.3 (47.6, 89.5) - 46.7 (24.8, 69.9)  
50-59 (22) 100.0 (82.5, 100.0) - 54.5 (34.6, 73.1)  
0-7 (116) 11.2 (6.5, 18.4) 31.0 (23.3, 40.0) 7.8 (4.0, 14.3) [20] 
8-14 (156) 37.8 (30.6, 45.6) 48.1 (40.4, 55.9) 12.8 (8.4, 19.0)  
15-21 (48) 68.7 (54.6, 80.1) 70.8 (56.7, 81.8) 27.1 (16.5, 41.1)  
22-28 (60) 75.0 (62.7, 84.3) 75.0 (62.7, 84.3) 51.7 (39.3, 63.8)  
 
Abbreviations: CI, confidence interval; IgG, immunoglobulin G; TgERP, Toxoplasma gondii embryogenesis-related protein; 
ROC, receiver operating characteristic; SD, standard deviation. 
IgG serological data were extracted from the literature from two studies in Northern Rio de Janeiro State, Brazil. One study 
collected blood samples by stratified sampling of individuals [19] and the other by sampling individuals associated with 10 public 
schools [20]. 95% binomial confidence intervals (CIs) were calculated using the Agresti-Coull method [25].  
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Table 2. Comparison of force of infection model fits for both datasets 
Age-force of infection Population datab Schools data  
Exponentially dampeda -19.31 -44.08 
Linear (positive intercept) -19.32 -44.08 
Linear (zero intercept) -25.44 -47.41 
Constant -19.32 -55.18 
 
Abbreviations: CI, confidence interval; TgERP, Toxoplasma gondii embryogenesis-related protein; IgG, immunoglobulin G. 
Model fitted to the population data [19] and schools data [20] using a maximum likelihood approach and assuming a proportion 
of oocyst infections of 1. Bold face signifies the best-fitting model based on comparison of model log likelihoods using a 
likelihood ratio test. Given a non-significant test at the 5% level, the simpler model was considered an adequate explanation of 
the data. Parameter 95% CIs were calculated by likelihood profiling [33]. Complete results for the population and schools data 
are given in Supplementary Tables S5 and S6 respectively. 
aInitially increasing with age to a peak and subsequently declining [29].  
bSince model fit (log likelihood) was invariant with different TgERP ELISA sensitivity and specificity values, a nominal set was 
chosen (80% and 95% respectively). The complete results are shown in Supplementary Table S5.   
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FIGURE LEGENDS 
 
Figure 1. Sero-catalytic model describing the age-seroprevalence dynamics of IgG and 
TgERP-IgG antibodies. The compartments represent serostatus (seronegative or 
seropositive) for each of the two antibodies, anti-T. gondii non-stage-specific IgG and anti-T. 
gondii embryogenesis-related protein (TgERP) IgG. The dynamics of the system are 
described by ordinary differential equations, based on transition rates (depicted by arrows) 
among states. Individuals beginning as seronegative for non-stage-specific IgG, IgG−, 
seroconvert to non-stage-specific IgG-positive, IgG+, at a rate determined by the age-specific 
force of infection (𝑎). Individuals seroconvert from 𝑇𝑔𝐸𝑅𝑃− to 𝑇𝑔𝐸𝑅𝑃+ at a rate defined by 
the product of  (𝑎) and the proportion of oocyst-derived infections, (𝑎) × p. The rate of 
seroreversion of anti-TgERP is defined by δTgERP, where 1/δTgERP defines the duration of 
anti-TgERP antibodies. Non-stage-specific IgG antibodies are presumed to be life-long and 
thus have no associated seroreversion parameter.  
 
Figure 2. Sensitivity analysis for a range of different diagnostic values for the standard 
deviation (SD) cut-off TgERP ELISA (x-axis format: sensitivity, specificity), assuming that all 
infections are oocyst-derived. Points and error bars show the maximum likelihood estimates 
for the duration of anti-TgERP IgG antibodies in years and 95% confidence intervals 
(estimated by likelihood profiling) [33]. Panel a) shows anti-TgERP IgG antibody duration 
estimates for the population data (N=128) [13] for all combinations of diagnostic performance 
values (sensitivity, specificity) and the best-fit constant (age-independent) age-force of 
infection profile (see Supplementary Table S5). Panel b) shows anti-TgERP IgG antibody 
duration estimates for the schools data (N=380) [15], for all combinations of diagnostic 
performance and the best-fitting linear age-force of infection profile (see Supplementary 
Table S6). 
 
Figure 3. Fitted and observed age-seroprevalence of Toxoplasma gondii from a population 
sample of 128 individuals in Campos dos Goytacazes, Rio de Janeiro state, Brazil [19]. 
Seroprevalence data are shown in grey and model estimates in black, with respective 95% 
confidence intervals (CIs) given by error bars and shaded grey areas. Modelled 
seroprevalence estimates are adjusted by the sensitivity and specificity of the relevant 
diagnostic test and use the best-fitting constant (age-independent) force of infection 
relationship. Confidence intervals associated with the fitted model were constructed by 
sampling parameter values from their approximate sampling distribution (see Supplementary 
Methods). Panels show the fitted versus observed seroprevalence of a) non-stage-specific 
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IgG, measured by modified agglutination test (MAT), and b) anti-T. gondii embryogenesis-
related protein (-TgERP) IgG measured by standard deviation (SD) cut-off ELISA. 
 
Figure 4. Fitted and observed age-seroprevalence of Toxoplasma gondii among 380 
individuals associated with 10 public schools in Campos dos Goytacazes, Rio de Janeiro 
State, Brazil [20]. Seroprevalence data are shown in grey and model estimates in black, with 
respective 95% confidence intervals (CIs) given by error bars and shaded grey areas. 
Modelled seroprevalence estimates are adjusted by the sensitivity and specificity of the 
relevant diagnostic test and use the best-fitting (linear) force of infection relationship. 
Confidence intervals associated with the fitted model were constructed by sampling 
parameter values from their approximate sampling distribution (see Supplementary 
Methods). Panels show the fitted versus observed seroprevalence of a) non-stage-specific 
IgG, measured by ELISA, b) anti-T. gondii embryogenesis-related protein (-TgERP) IgG 
measured by receiver operating characteristic (ROC) curve cut-off ELISA, and c) anti-TgERP 
IgG measured by standard deviation (SD) cut-off ELISA. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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